Literature DB >> 7700385

A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor.

P Singh1, J Coe, W Hong.   

Abstract

The Saccharomyces cerevisiae SNF2/SWI2 protein is essential for the regulated expression of a variety of genes. A human SWI2/SNF2 homologue, hBrm, is a positive participant in glucocorticoid-receptor-mediated transcription, but its mechanism of action is not known. The retinoblastoma protein, RB, has also been shown to stimulate the transcription of several genes, although the target for RB has not been identified in any of these transcriptional events. Here we show that RB upregulates glucocorticoid-receptor-mediated transcription. The effect of either RB or hBrm is dependent on the presence of the other. Furthermore, we demonstrate that RB and hBrm interact with one another in vitro and in vivo. These results highlight a new role for RB, which is to interact with hBrm in order to potentiate glucocorticoid-receptor-activated transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700385     DOI: 10.1038/374562a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  61 in total

1.  Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.

Authors:  F A Dick; E Sailhamer; N J Dyson
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression.

Authors:  C Lemercier; K Duncliffe; I Boibessot; H Zhang; A Verdel; D Angelov; S Khochbin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation.

Authors:  Brigitte Bourachot; Moshe Yaniv; Christian Muchardt
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

5.  Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression.

Authors:  Chiaki Takahashi; Bernardo Contreras; Roderick T Bronson; Massimo Loda; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

6.  RB and hbrm cooperate to repress the activation functions of E2F1.

Authors:  D Trouche; C Le Chalony; C Muchardt; M Yaniv; T Kouzarides
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

7.  Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins.

Authors:  B E Strober; J L Dunaief; S P Goff
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

8.  SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells.

Authors:  C Sumi-Ichinose; H Ichinose; D Metzger; P Chambon
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

9.  The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer?

Authors:  Kay F Macleod
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

10.  The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer.

Authors:  Hui Shen; Nathan Powers; Nitin Saini; Clay E S Comstock; Ankur Sharma; Katherine Weaver; Monica P Revelo; William Gerald; Erin Williams; Walter J Jessen; Bruce J Aronow; Gary Rosson; Bernard Weissman; Christian Muchardt; Moshe Yaniv; Karen E Knudsen
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.